Evidence map›Paper›PMID 36889308›Full record

ArticleAmerican journal of human genetics2023

Variation in ERAP2 has opposing effects on severe respiratory infection and autoimmune disease.

Fergus Hamilton, Alexander J Mentzer, Tom Parks, J Kenneth Baillie, George Davey Smith, Peter Ghazal, Nicholas J Timpson

Open access · hybridAbstract read
In one paragraph

Article in American journal of human genetics, 2023. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 19 papers.

0numbers the graph read from it
0cells of the map it votes in
19citing papers in PubMed
5.8field-weighted citation impact, top 3% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

19 citing papers in PubMed, 34 citations in OpenAlex.

  1. Article
  2. Review
  3. Article
  4. Article
  5. Article
  6. Article
  7. Article
  8. Article
  9. Review
  10. Article
  11. Article
  12. Review
  13. Article
  14. Article
  15. Association ofFrontiers in immunology · 2024
    Article
  16. Article
  17. Review
  18. Article
  19. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

7 authors at 5 institutions in 1 country.

Fergus HamiltonMRC Integrative Epidemiology Unit, University of Bristol, Bristol, UK; Infection Science, North Bristol NHS Trust, Bristol, UK. Electronic address: fergus.hamilton@bristol.ac.uk.
Alexander J MentzerWellcome Centre For Human Genetics, University of Oxford, Oxford, UK.
Tom ParksWellcome Centre For Human Genetics, University of Oxford, Oxford, UK; Department of Infectious Disease, Imperial College London, London, UK.
J Kenneth BaillieBaillie Gifford Pandemic Science Hub, Centre for Inflammation Research, University of Edinburgh, Edinburgh, UK; Roslin Institute, University of Edinburgh, Edinburgh, UK; Intensive Care Unit, Royal Infirmary of Edinburgh, Edinburgh, UK.
George Davey SmithMRC Integrative Epidemiology Unit, University of Bristol, Bristol, UK.
Peter GhazalProject Sepsis, Cardiff University, Cardiff, UK.
Nicholas J TimpsonMRC Integrative Epidemiology Unit, University of Bristol, Bristol, UK; Population Health Sciences, Bristol Medical School, University of Bristol, Bristol, UK.
Centre for Human Genetics · GBUniversity of Bristol · GBCardiff University · GBNorth Bristol NHS Trust · GBRoslin Institute · GB

Funding

Biotechnology and Biological Sciences Research Council BB/P013732/1Biotechnology and Biological Sciences Research Council BB/P013759/1Cancer Research UK C18281/A29019Department of Health BRC-1215-2001Medical Research Council MC_PC_19025Medical Research Council MC_UU_00011/1Medical Research Council MC_UU_00032/1Wellcome TrustWellcome Trust 202802/Z/16/ZWellcome Trust 217065/Z/19/ZWellcome Trust 222098/Z/20/ZWellcome Trust 222894/Z/21/ZWellcome Trust 223164/Z/21/Z
6 · The paper itself

Abstract

ERAP2 is an aminopeptidase involved in immunological antigen presentation. Genotype data in human samples from before and after the Black Death, an epidemic due to Yersinia pestis, have marked changes in allele frequency of the single-nucleotide polymorphism (SNP) rs2549794, with the T allele suggested to be deleterious during this period, while ERAP2 is also implicated in autoimmune diseases. This study explored the association between variation at ERAP2 and (1) infection, (2) autoimmune disease, and (3) parental longevity. Genome-wide association studies (GWASs) of these outcomes were identified in contemporary cohorts (UK Biobank, FinnGen, and GenOMICC). Effect estimates were extracted for rs2549794 and rs2248374, a haplotype tagging SNP. Additionally, cis expression and protein quantitative trait loci (QTLs) for ERAP2 were used in Mendelian randomization (MR) analyses. Consistent with decreased survival in the Black Death, the T allele of rs2549794 showed evidence of association with respiratory infection (odds ratio; OR for pneumonia 1.03; 95% CI 1.01-1.05). Effect estimates were larger for more severe phenotypes (OR for critical care admission with pneumonia 1.08; 95% CI 1.02-1.14). In contrast, opposing effects were identified for Crohn disease (OR 0.86; 95% CI 0.82-0.90). This allele was shown to associate with decreased ERAP2 expression and protein levels, independent of haplotype. MR analyses suggest that ERAP2 expression may be mediating disease associations. Decreased ERAP2 expression is associated with severe respiratory infection with an opposing association with autoimmune diseases. These data support the hypothesis of balancing selection at this locus driven by autoimmune and infectious disease.

Indexed as

Autoimmune DiseasesPlagueAminopeptidasesGenetic Predisposition to DiseaseGenome-Wide Association StudyGenotypeHaplotypesHumansPolymorphism, Single NucleotideAminopeptidasesERAP2 protein, humanbalancing selectionCOVID-19ERAP2infectionMendelian randomizationpneumonia

Identifiers

PMID36889308
PMCPMC10119032
OpenAlexW4323355347

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.